Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorScripps Health
About this trial
This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.
Eligibility criteria
Qualifiers
Male or female patients aged 18 or older at the time of study informed consent.
Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
Patients have access to digital device capable of downloading study app
Patients able to read study documents and able to complete informed consent within the study app
Disqualifiers
Failed prior alloHSCT within the past 6 months
Trial design
Treatments tested in this trial
- App-based Educational Intervention
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Scripps Health
Lead sponsor
Scripps Clinic
Collaborator
Source ClinicalTrials.gov